Endo Cut Loose From 9 Suits In Darvocet, Darvon MDL

Law360, New York (April 4, 2012, 7:22 PM EDT) -- A Kentucky federal judge on Wednesday freed Endo Pharmaceuticals Inc. from nine suits in multidistrict litigation over injuries tied to painkillers Darvocet, Darvon and their generic equivalents.

Endo and Endo Pharmaceutical Holdings Inc. successfully argued that they could not be held liable for generic propoxyphene products that their subsidiaries manufactured.

The plaintiffs had contended that additional discovery was needed to determine whether the Endo defendants could be held liable under exceptions to the general rule that a parent company can't be held responsible for the acts...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.